Atlas FDA

INFORM HER2 DUAL ISH DNA PROBE COCKTAIL

FDA premarket approval P100027/S021 · decided 2015-03-19

Approval details

PMA number
P100027
Supplement
S021
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
INFORM HER2 DUAL ISH DNA PROBE COCKTAIL
Generic name
Chromogenic in situ hybridization, nucleic acid amplification, HER2/NEU gene, breast cancer
Applicant
Ventana Medical Systems, Inc.
Date received
2015-02-11
Decision date
2015-03-19
Days to decision
36 days
Decision code
OK30
Product code
NYQ
Advisory committee
Pathology
Expedited review
No
Location
Tucson, AZ
Statement
CHANGE IN THE METRIC USED TO MONITOR THE MANUFACTURING PROCESS OF THE INFORM HER2 DUAL ISH DNA PROBE COCKTAIL. IN ADDITION, THE METRIC CHANGE, AN INCREASE IN THE NUMBER OF SLIDES TESTED FOR FINAL ACCEPTANCE TESTING, AS WELL AS AN EXPANSION OF THAT FINAL ACCEPTANCE TESTING TO INCLUDE GASTRIC TISSUE, WILL BE IMPLEMENTED.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Roche Digital Pathology Dx (K242783)Ventana Medical Systems, Inc.2024-12-17
VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail (08507023001) (DEN240025)Ventana Medical Systems, Inc.2024-12-05
Roche Digital Pathology Dx (VENTANA DP 200) (K232879)Ventana Medical Systems, Inc.2024-06-14
CINtec Histology (K212176)Ventana Medical Systems, Inc.2021-12-10
VENTANA CD30 (Ber-H2) RxDx Assay (K172471)Ventana Medical Systems, Inc.2018-05-08
CINtec Histology (50 tests), CINtec Histology (250 tests) (DEN160019)Ventana Medical Systems, Inc.2017-03-04
Virtuoso System for IHC PR (1E2) using iScan HT (K142965)Ventana Medical Systems, Inc.2015-07-16
VIRTUOSO SYSTEM FOR IHC ER (SP1) WITH BENCHMARK ULTRA STAINER (K140465)Ventana Medical Systems, Inc.2014-03-20